These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 25346390

  • 1. Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
    Uriarte I, Latasa MU, Carotti S, Fernandez-Barrena MG, Garcia-Irigoyen O, Elizalde M, Urtasun R, Vespasiani-Gentilucci U, Morini S, de Mingo A, Mari M, Corrales FJ, Prieto J, Berasain C, Avila MA.
    Int J Cancer; 2015 May 15; 136(10):2469-75. PubMed ID: 25346390
    [Abstract] [Full Text] [Related]

  • 2. The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice.
    Li Q, Zhao Q, Zhang C, Zhang P, Hu A, Zhang L, Schroder PM, Ma Y, Guo Z, Zhu X, He X.
    J Physiol Biochem; 2018 May 15; 74(2):247-260. PubMed ID: 29468415
    [Abstract] [Full Text] [Related]

  • 3. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M, Luo J, Chen M, Yang H, Learned RM, DePaoli AM, Tian H, Ling L.
    J Hepatol; 2017 Jun 15; 66(6):1182-1192. PubMed ID: 28189755
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
    Alvarez-Sola G, Uriarte I, Latasa MU, Fernandez-Barrena MG, Urtasun R, Elizalde M, Barcena-Varela M, Jiménez M, Chang HC, Barbero R, Catalán V, Rodríguez A, Frühbeck G, Gallego-Escuredo JM, Gavaldà-Navarro A, Villarroya F, Rodriguez-Ortigosa CM, Corrales FJ, Prieto J, Berraondo P, Berasain C, Avila MA.
    Gut; 2017 Oct 15; 66(10):1818-1828. PubMed ID: 28119353
    [Abstract] [Full Text] [Related]

  • 5. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
    Williams CM, Harper Calderon J, E H, Jimenez Y, Barringer K, Carbonaro M, Molina-Portela MDP, Thurston G, Li Z, Daly C.
    FASEB J; 2021 Feb 15; 35(2):e21286. PubMed ID: 33484478
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
    Cui G, Martin RC, Jin H, Liu X, Pandit H, Zhao H, Cai L, Zhang P, Li W, Li Y.
    J Exp Clin Cancer Res; 2018 Jul 04; 37(1):136. PubMed ID: 29973237
    [Abstract] [Full Text] [Related]

  • 7. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice.
    Uriarte I, Fernandez-Barrena MG, Monte MJ, Latasa MU, Chang HC, Carotti S, Vespasiani-Gentilucci U, Morini S, Vicente E, Concepcion AR, Medina JF, Marin JJ, Berasain C, Prieto J, Avila MA.
    Gut; 2013 Jun 04; 62(6):899-910. PubMed ID: 23292666
    [Abstract] [Full Text] [Related]

  • 8. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T, Kim YC, Byun S, Kim DH, Seok S, Suino-Powell K, Xu HE, Kemper B, Kemper JK.
    Mol Endocrinol; 2016 Jan 04; 30(1):92-103. PubMed ID: 26505219
    [Abstract] [Full Text] [Related]

  • 9. Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development.
    Schumacher JD, Kong B, Wu J, Rizzolo D, Armstrong LE, Chow MD, Goedken M, Lee YH, Guo GL.
    Hepatology; 2020 Feb 04; 71(2):670-685. PubMed ID: 31206730
    [Abstract] [Full Text] [Related]

  • 10. Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis.
    Alvarez-Sola G, Uriarte I, Latasa MU, Urtasun R, Bárcena-Varela M, Elizalde M, Jiménez M, Rodriguez-Ortigosa CM, Corrales FJ, Fernández-Barrena MG, Berasain C, Avila MA.
    Dig Dis; 2017 Feb 04; 35(3):158-165. PubMed ID: 28249259
    [Abstract] [Full Text] [Related]

  • 11. Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.
    Zhou M, Wang X, Phung V, Lindhout DA, Mondal K, Hsu JY, Yang H, Humphrey M, Ding X, Arora T, Learned RM, DePaoli AM, Tian H, Ling L.
    Cancer Res; 2014 Jun 15; 74(12):3306-16. PubMed ID: 24728076
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma.
    Li Y, Zhang W, Doughtie A, Cui G, Li X, Pandit H, Yang Y, Li S, Martin R.
    Oncotarget; 2016 Aug 09; 7(32):52329-52339. PubMed ID: 27447573
    [Abstract] [Full Text] [Related]

  • 13. FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels.
    Shang Q, Guo GL, Honda A, Saumoy M, Salen G, Xu G.
    J Lipid Res; 2013 Oct 09; 54(10):2606-14. PubMed ID: 23852734
    [Abstract] [Full Text] [Related]

  • 14. TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.
    Bhat N, Esteghamat F, Chaube BK, Gunawardhana K, Mani M, Thames C, Jain D, Ginsberg HN, Fernandes-Hernando C, Mani A.
    FASEB J; 2022 Mar 09; 36(3):e22185. PubMed ID: 35133032
    [Abstract] [Full Text] [Related]

  • 15. A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.
    Nicholes K, Guillet S, Tomlinson E, Hillan K, Wright B, Frantz GD, Pham TA, Dillard-Telm L, Tsai SP, Stephan JP, Stinson J, Stewart T, French DM.
    Am J Pathol; 2002 Jun 09; 160(6):2295-307. PubMed ID: 12057932
    [Abstract] [Full Text] [Related]

  • 16. Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys.
    Pai R, French D, Ma N, Hotzel K, Plise E, Salphati L, Setchell KD, Ware J, Lauriault V, Schutt L, Hartley D, Dambach D.
    Toxicol Sci; 2012 Apr 09; 126(2):446-56. PubMed ID: 22268002
    [Abstract] [Full Text] [Related]

  • 17. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
    Ho HK, Pok S, Streit S, Ruhe JE, Hart S, Lim KS, Loo HL, Aung MO, Lim SG, Ullrich A.
    J Hepatol; 2009 Jan 09; 50(1):118-27. PubMed ID: 19008009
    [Abstract] [Full Text] [Related]

  • 18. Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic induction.
    Wright TJ, Ladher R, McWhirter J, Murre C, Schoenwolf GC, Mansour SL.
    Dev Biol; 2004 May 01; 269(1):264-75. PubMed ID: 15081372
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, Feng ZQ, Zhang JP.
    Chin Med J (Engl); 2011 Nov 01; 124(22):3794-9. PubMed ID: 22340243
    [Abstract] [Full Text] [Related]

  • 20. G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis.
    Wei T, Chen W, Wen L, Zhang J, Zhang Q, Yang J, Liu H, Chen BW, Zhou Y, Feng X, Yang Q, Bai X, Liang T.
    Cancer Lett; 2016 Nov 28; 382(2):195-202. PubMed ID: 27594673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.